{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-061859","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.047477+00:00","generated_at":"2026-05-22T23:59:44.166489+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ATEC Q1 revenue $169M (+22% YoY); raises FY guidance to $734M; refinances convertible debt to 2030","bullets":["Surgical revenue $152M (+24%), driven by 17% procedural volume growth and 18% new surgeon adoption increase.","GAAP net loss $52M; Adjusted EBITDA $11M (6% margin), improving 840 bps YoY.","FY2025 revenue guidance raised to ~$734M (from $732M) and adjusted EBITDA to ~$78M (from $75M).","Refinanced convertible debt extending maturity to 2030; ending cash $153M.","Free cash use improved $55M versus Q1 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-061859","json":"https://secwatch.observer/filing/0000950170-25-061859.json","markdown":"https://secwatch.observer/filing/0000950170-25-061859.md","text":"https://secwatch.observer/filing/0000950170-25-061859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000095017025061859/0000950170-25-061859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000095017025061859/atec-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T23:59:44.166489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}